Posted On: 05/20/2014 9:18:01 AM
Post# of 94302
$PPCH Intellectual Property – Current Status Filed an international patent application: Enhanced proenzyme formulations and combination therapies comprising trypsinogen and chymotrypsin
Written opinion issued indicated the patent claims covering PRP were novel. Entered National Phase, Apr 2012, filing in all major global regions.
Further patents planned to capture and protect further enhanced formulations, combination treatments, use of recombinant products, modes of action & molecular targets
Our portfolio includes an extensive amount of confidential information and expertise in relation to the development and formulation of proenzyme based combination therapies
Written opinion issued indicated the patent claims covering PRP were novel. Entered National Phase, Apr 2012, filing in all major global regions.
Further patents planned to capture and protect further enhanced formulations, combination treatments, use of recombinant products, modes of action & molecular targets
Our portfolio includes an extensive amount of confidential information and expertise in relation to the development and formulation of proenzyme based combination therapies
(0)
(0)
